|
| 36239995 | A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in Glioblastoma. | Clin Cancer Res | 2023 |
| 37656187 | Integrative multi-omics reveals two biologically distinct groups of pilocytic astrocytoma. | Acta Neuropathol | 2023 |
| 37740942 | D-2-hydroxyglutarate regulates human brain vascular endothelial cell proliferation and barrier function. | J Neuropathol Exp Neurol | 2023 |
| 37648934 | Long-term neurocognitive function and quality of life after multimodal therapy in adult glioma patients: a prospective long-term follow-up. | J Neurooncol | 2023 |
| 37573572 | Spatial immune profiling of glioblastoma identifies an inflammatory, perivascular phenotype associated with longer survival. | Acta Neuropathol | 2023 |
| 37976029 | The long non-coding RNA OTX2-AS1 promotes tumor growth and predicts response to BCL-2 inhibition in medulloblastoma. | J Neurooncol | 2023 |
| 37922934 | A framework for standardised tissue sampling and processing during resection of diffuse intracranial glioma: joint recommendations from four RANO groups. | Lancet Oncol | 2023 |
| 35802605 | Quantitative proteomic landscapes of primary and recurrent glioblastoma reveal a protumorigeneic role for FBXO2-dependent glioma-microenvironment interactions. | Neuro Oncol | 2023 |
| 37279174 | Molecular diagnostic tools for the World Health Organization (WHO) 2021 classification of gliomas, glioneuronal and neuronal tumors; an EANO guideline. | Neuro Oncol | 2023 |
| 37277265 | Long-term survival with IDH wildtype glioblastoma: first results from the ETERNITY Brain Tumor Funders' Collaborative Consortium (EORTC 1419). | Eur J Cancer | 2023 |
| 36999511 | Update on quality assurance in neuropathology: Summary of the round robin trials on <i>TERT</i> promoter mutation, <i>H3-3A</i> mutation, 1p/19q codeletion, and <i>KIAA1549::BRAF</i> fusion testing in Germany in 2020 and 2021. | Clin Neuropathol | 2023 |
| 36639156 | Tacedinaline (CI-994), a class I HDAC inhibitor, targets intrinsic tumor growth and leptomeningeal dissemination in MYC-driven medulloblastoma while making them susceptible to anti-CD47-induced macrophage phagocytosis via NF-kB-TGM2 driven tumor inflammation. | J Immunother Cancer | 2023 |
| 36632791 | EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selection. | Neuro Oncol | 2023 |
| 35322237 | Author Correction: EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood. | Nat Rev Clin Oncol | 2022 |
| 35804936 | WNT/β-Catenin-Mediated Resistance to Glucose Deprivation in Glioblastoma Stem-like Cells. | Cancers (Basel) | 2022 |
| 35379801 | EIF4EBP1 is transcriptionally upregulated by MYCN and associates with poor prognosis in neuroblastoma. | Cell Death Discov | 2022 |
| 35796933 | Mid-term treatment-related cognitive sequelae in glioma patients. | J Neurooncol | 2022 |
| 35831316 | The HHIP-AS1 lncRNA promotes tumorigenicity through stabilization of dynein complex 1 in human SHH-driven tumors. | Nat Commun | 2022 |
| 35599302 | AMPLIFY-NEOVAC: a randomized, 3-arm multicenter phase I trial to assess safety, tolerability and immunogenicity of IDH1-vac combined with an immune checkpoint inhibitor targeting programmed death-ligand 1 in isocitrate dehydrogenase 1 mutant gliomas. | Neurol Res Pract | 2022 |
| 35361262 | Droplet digital PCR-based analyses for robust, rapid, and sensitive molecular diagnostics of gliomas. | Acta Neuropathol Commun | 2022 |
| 36127323 | Primary cilia contribute to the aggressiveness of atypical teratoid/rhabdoid tumors. | Cell Death Dis | 2022 |
| 35977725 | Anaplastic ganglioglioma-A diagnosis comprising several distinct tumour types. | Neuropathol Appl Neurobiol | 2022 |
| 34982196 | First-line high-dose therapy and autologous blood stem cell transplantation in patients with primary central nervous system non-Hodgkin lymphomas-a single-centre experience in 61 patients. | Ann Hematol | 2022 |
| 34952462 | Glutaredoxin 2 promotes SP-1-dependent CSPG4 transcription and migration of wound healing NG2 glia and glioma cells: Enzymatic Taoism. | Redox Biol | 2022 |
| 35012690 | Pleomorphic xanthoastrocytoma is a heterogeneous entity with pTERT mutations prognosticating shorter survival. | Acta Neuropathol Commun | 2022 |
| 35307743 | Intratumoral heterogeneity of MYC drives medulloblastoma metastasis and angiogenesis. | Neuro Oncol | 2022 |
| 35171829 | Development and external validation of a clinical prediction model for survival in patients with IDH wild-type glioblastoma. | J Neurosurg | 2022 |
| 35228525 | Eukaryotic translation initiation factor 4E binding protein 1 (EIF4EBP1) expression in glioblastoma is driven by ETS1- and MYBL2-dependent transcriptional activation. | Cell Death Discov | 2022 |
| 32696543 | Targeted next-generation sequencing of adult gliomas for retrospective prognostic evaluation and up-front diagnostics. | Neuropathol Appl Neurobiol | 2021 |
| 33879448 | Cross-Species Genomics Reveals Oncogenic Dependencies in ZFTA/C11orf95 Fusion-Positive Supratentorial Ependymomas. | Cancer Discov | 2021 |
| 33508126 | Genome-wide methylation profiling of glioblastoma cell-derived extracellular vesicle DNA allows tumor classification. | Neuro Oncol | 2021 |
| 33866410 | Circular RNA profiling distinguishes medulloblastoma groups and shows aberrant RMST overexpression in WNT medulloblastoma. | Acta Neuropathol | 2021 |
| 33779999 | A common classification framework for histone sequence alterations in tumours: an expert consensus proposal. | J Pathol | 2021 |
| 33631540 | Telomerase reverse transcriptase promoter mutation- and O<sup>6</sup>-methylguanine DNA methyltransferase promoter methylation-mediated sensitivity to temozolomide in isocitrate dehydrogenase-wild-type glioblastoma: is there a link? | Eur J Cancer | 2021 |
| 33578810 | Integrative Genomic Analyses of Patient-Matched Intracranial and Extracranial Metastases Reveal a Novel Brain-Specific Landscape of Genetic Variants in Driver Genes of Malignant Melanoma. | Cancers (Basel) | 2021 |
| 34618539 | Integrated Molecular-Morphologic Meningioma Classification: A Multicenter Retrospective Analysis, Retrospectively and Prospectively Validated. | J Clin Oncol | 2021 |
| 34584066 | The long non-coding RNA HOTAIRM1 promotes tumor aggressiveness and radiotherapy resistance in glioblastoma. | Cell Death Dis | 2021 |
| 34628166 | Longitudinal stability of molecular alterations and drug response profiles in tumor spheroid cell lines enables reproducible analyses. | Biomed Pharmacother | 2021 |
| 34536122 | GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma types. | Acta Neuropathol | 2021 |
| 34680261 | Frequent Epigenetic Inactivation of DIRAS-1 and DIRAS-2 Contributes to Chemo-Resistance in Gliomas. | Cancers (Basel) | 2021 |
| 34504133 | Prognostic role of Ki-67 in glioblastomas excluding contribution from non-neoplastic cells. | Sci Rep | 2021 |
| 34277025 | Chemotherapy for adult patients with spinal cord gliomas. | Neurooncol Pract | 2021 |
| 34185076 | The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. | Neuro Oncol | 2021 |
| 34128073 | Sarcomatous Meningioma: Diagnostic Pitfalls and the Utility of Molecular Testing. | J Neuropathol Exp Neurol | 2021 |
| 33937035 | Radiomic Analysis to Predict Outcome in Recurrent Glioblastoma Based on Multi-Center MR Imaging From the Prospective DIRECTOR Trial. | Front Oncol | 2021 |
| 34355256 | Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial neuroepithelial tumors. | Acta Neuropathol | 2021 |
| 33113214 | MGMT promoter methylation analysis for allocating combined CCNU/TMZ chemotherapy: Lessons learned from the CeTeG/NOA-09 trial. | Int J Cancer | 2021 |
| 33244787 | The presence of TIM-3 positive cells in WHO grade III and IV astrocytic gliomas correlates with isocitrate dehydrogenase mutation status. | Brain Pathol | 2021 |
| 33130881 | A subset of pediatric-type thalamic gliomas share a distinct DNA methylation profile, H3K27me3 loss and frequent alteration of EGFR. | Neuro Oncol | 2021 |
| 33293629 | EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood. | Nat Rev Clin Oncol | 2021 |